AstraZeneca: FDA approves application for Enhertu

AstraZeneca: new approval for Tagrisso in the USA

AstraZeneca: Disappointment over Dato-DXd in breast cancer

AstraZeneca: disappointment over Dato-DXd in breast cancer

AstraZeneca: several positive results in cancer

AstraZeneca: Deutsche Bank goes ‘sale’

AstraZeneca: Deutsche Bank goes ‘sale’